R
Rapamycin
Analyzing
Extracting target signal
Rapamycin
Extracting target signal
Rapamycin
Arcmira media summary
Browse Rapamycin reviews, demos & launch coverage — 14 indexed from Tim Ferriss & CNN, updated May 2026.
Discussed as an interesting but risky longevity intervention.
Longevity drug that Bryan Johnson publicly stopped taking due to side effects.
Described as the gold standard drug for slowing aging in laboratory animals.
A drug being studied for its potential longevity effects in dogs.
Arcmira tracks 14 indexed media appearances or mentions for Rapamycin, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "My Current Longevity Stack" with transcript-derived context and links when available.
Rapamycin is connected to Longevity, Longevity science, Diabetes Medication in Arcmira's media graph.
14
Mentions
489.1K
Views
The trendline is visible, but the dated evidence behind Rapamycin is in the premium layer.
“Discussed as an interesting but risky longevity intervention.”
“Longevity drug that Bryan Johnson publicly stopped taking due to side effects.”
“Described as the gold standard drug for slowing aging in laboratory animals.”
“A drug being studied for its potential longevity effects in dogs.”